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   The carcinoembryopic anti．cren （CEA） and ABO （H） blood group antigens of47 bladder
tumors were investigated by immunohistochemistry （CEA by peroxidase－antiperoxidase meth－
od and blood group antigens by Avidin－biotin－peroxidase complex method） and the results
were compared with the histopathological diag． n6sis．
   ［rwenty five percent of the bladder tumors had CEA－positive tumor cells． They were
found in I I．1％ of prlr1 cases， in 12．5％ of pT2 cases， 70．0％ of pT3 cases and 50．0％ pf pT4
cases and were also found in 13．3％ of grade 1 cases， in 50．0％ of grade II cases and in 40．0
％ of grade III cases． On the other hand， positive blood group antigen cells were found in
85．29． of pTl cases， 50．0％ of pT2 cases， 20．0％ of pT3 cases and 50．0．0／o of the pT4 cases and
alsb’ in 80．0％， ’ef the grade 1 cases， ‘ll．1％ of the ．［rrade II cases， and 20．0％ of the grade III
g4．sg．s．． A．st．at，istica！ difference vyas seen between the ldw stage （pTi） and high stage cases
．（pT2f：．y．p［lr．4）．an． d． be．．twc．en．the． low gr．．ad．q （G－1）． and high grade cases （G－II， III） （P〈O．Ol）
f・ゆ・・h CEA．・hd・he b1・・dl g…pan・ig・n・wh量・h were…ti・tically rel・t・d（P＜0・01）・
   The detection of CEA and that of the blood group antigens may be valuable for assisting
the histopathological findings in the case of the small biopsy specimens especially ln addition
to the prediction of the malignant potential．
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Table 1． Total cases of the bladder cancer in this study’
Pathological Stage
No．pTs pTi pT2 pTapT略
！／1，lg！lg．XggSgg．Lgzgs！g｛tlicalGrade
 Gi Gz G3
Primary
Tumor 29i5 7 5 2 17 9 3
Recurrent
Tu皿or 18 12 ユ． 5 o 13 3 2
（Tota1四〇曝Pts）472 8 10 2 30・ 12 5
Table 2． lmmunoperoxidase methods
Blood Group Antigens




Secendary Swine anti－rabbit immunogloburin
TertiaryPeroxidase－anti－peroxidase

























































Fig． 1． The mfiltrating carcinoma cells of the blad．de－r shoys She
    presence of carcinoembryomc antigen by PAP ir｝pthod





Fig． 2． rl he histological section of Larcinoma m
    situ of the bladder shows the presence
    of the blood group antigen on urothelium，
    vascular endothelium and erythropytes
    by ABC method． （300×）
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Relationship between CEA一 or blood group antigen status and
histo－pathological stage in 47 transitional cell carcinomas of
the bladder

























（Total＞ 47 35 12 17 30
pTi
pTぺpT6
27 24 3 4
20 11 9 13
23
7
Table 4．Relationship between CEA一 or blood group antigen status and
histological grade in transitiQnal cell carcinomas of the
bladder






























































Relationship between carcinoembryonic antigen biosynthesis and absence













（Total No．Pts） 35 12 47
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